Aberrant	O
gene	B:C0017337
-	O
specific	O
DNA	O
methylation	I:C0376452
signature	O
analysis	O
in	O
cervical	O
cancer	I:C4048328
Multicomponent	O
molecular	O
modifications	O
such	O
as	O
DNA	O
methylation	I:C0376452
may	O
offer	O
sensitive	O
and	O
specific	O
cervical	O
intraepithelial	I:C0206708
neoplasia	I:C0206708
and	O
cervical	O
cancer	I:C4048328
biomarkers	O
.	O

Aberrant	O
gene	O
-	O
specific	O
DNA	B:C0376452
methylation	I:C0376452
signature	O
analysis	O
in	O
cervical	O
cancer	I:C4048328
Multicomponent	O
molecular	O
modifications	O
such	O
as	O
DNA	O
methylation	I:C0376452
may	O
offer	O
sensitive	O
and	O
specific	O
cervical	O
intraepithelial	I:C0206708
neoplasia	I:C0206708
and	O
cervical	O
cancer	I:C4048328
biomarkers	O
.	O

Aberrant	O
gene	O
-	O
specific	O
DNA	O
methylation	I:C0376452
signature	O
analysis	B:C0936012
in	O
cervical	O
cancer	I:C4048328
Multicomponent	O
molecular	O
modifications	O
such	O
as	O
DNA	O
methylation	I:C0376452
may	O
offer	O
sensitive	O
and	O
specific	O
cervical	O
intraepithelial	I:C0206708
neoplasia	I:C0206708
and	O
cervical	O
cancer	I:C4048328
biomarkers	O
.	O

Aberrant	O
gene	O
-	O
specific	O
DNA	O
methylation	I:C0376452
signature	O
analysis	O
in	O
cervical	B:C4048328
cancer	I:C4048328
Multicomponent	O
molecular	O
modifications	O
such	O
as	O
DNA	O
methylation	I:C0376452
may	O
offer	O
sensitive	O
and	O
specific	O
cervical	O
intraepithelial	I:C0206708
neoplasia	I:C0206708
and	O
cervical	O
cancer	I:C4048328
biomarkers	O
.	O

Aberrant	O
gene	O
-	O
specific	O
DNA	O
methylation	I:C0376452
signature	O
analysis	O
in	O
cervical	O
cancer	I:C4048328
Multicomponent	O
molecular	O
modifications	O
such	O
as	O
DNA	B:C0376452
methylation	I:C0376452
may	O
offer	O
sensitive	O
and	O
specific	O
cervical	O
intraepithelial	I:C0206708
neoplasia	I:C0206708
and	O
cervical	O
cancer	I:C4048328
biomarkers	O
.	O

Aberrant	O
gene	O
-	O
specific	O
DNA	O
methylation	I:C0376452
signature	O
analysis	O
in	O
cervical	O
cancer	I:C4048328
Multicomponent	O
molecular	O
modifications	O
such	O
as	O
DNA	O
methylation	I:C0376452
may	O
offer	O
sensitive	O
and	O
specific	O
cervical	B:C0206708
intraepithelial	I:C0206708
neoplasia	I:C0206708
and	O
cervical	O
cancer	I:C4048328
biomarkers	O
.	O

Aberrant	O
gene	O
-	O
specific	O
DNA	O
methylation	I:C0376452
signature	O
analysis	O
in	O
cervical	O
cancer	I:C4048328
Multicomponent	O
molecular	O
modifications	O
such	O
as	O
DNA	O
methylation	I:C0376452
may	O
offer	O
sensitive	O
and	O
specific	O
cervical	O
intraepithelial	I:C0206708
neoplasia	I:C0206708
and	O
cervical	B:C4048328
cancer	I:C4048328
biomarkers	O
.	O

Aberrant	O
gene	O
-	O
specific	O
DNA	O
methylation	I:C0376452
signature	O
analysis	O
in	O
cervical	O
cancer	I:C4048328
Multicomponent	O
molecular	O
modifications	O
such	O
as	O
DNA	O
methylation	I:C0376452
may	O
offer	O
sensitive	O
and	O
specific	O
cervical	O
intraepithelial	I:C0206708
neoplasia	I:C0206708
and	O
cervical	O
cancer	I:C4048328
biomarkers	B:C0041366
.	O

In	O
this	O
study	B:C2603343
,	O
we	O
tested	O
cervical	O
tissues	O
at	O
various	O
stages	O
of	O
tumor	O
progression	I:C0178874
for	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
and	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
levels	O
and	O
also	O
DNA	O
promoter	O
methylation	O
profile	O
of	O
a	O
panel	O
of	O
genes	O
for	O
its	O
diagnostic	O
potential	O
.	O

In	O
this	O
study	O
,	O
we	O
tested	O
cervical	B:C0027530
tissues	O
at	O
various	O
stages	O
of	O
tumor	O
progression	I:C0178874
for	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
and	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
levels	O
and	O
also	O
DNA	O
promoter	O
methylation	O
profile	O
of	O
a	O
panel	O
of	O
genes	O
for	O
its	O
diagnostic	O
potential	O
.	O

In	O
this	O
study	O
,	O
we	O
tested	O
cervical	O
tissues	B:C0040300
at	O
various	O
stages	O
of	O
tumor	O
progression	I:C0178874
for	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
and	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
levels	O
and	O
also	O
DNA	O
promoter	O
methylation	O
profile	O
of	O
a	O
panel	O
of	O
genes	O
for	O
its	O
diagnostic	O
potential	O
.	O

In	O
this	O
study	O
,	O
we	O
tested	O
cervical	O
tissues	O
at	O
various	O
stages	O
of	O
tumor	B:C0178874
progression	I:C0178874
for	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
and	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
levels	O
and	O
also	O
DNA	O
promoter	O
methylation	O
profile	O
of	O
a	O
panel	O
of	O
genes	O
for	O
its	O
diagnostic	O
potential	O
.	O

In	O
this	O
study	O
,	O
we	O
tested	O
cervical	O
tissues	O
at	O
various	O
stages	O
of	O
tumor	O
progression	I:C0178874
for	O
5	B:C0049308
-	I:C0049308
methylcytosine	I:C0049308
and	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
levels	O
and	O
also	O
DNA	O
promoter	O
methylation	O
profile	O
of	O
a	O
panel	O
of	O
genes	O
for	O
its	O
diagnostic	O
potential	O
.	O

In	O
this	O
study	O
,	O
we	O
tested	O
cervical	O
tissues	O
at	O
various	O
stages	O
of	O
tumor	O
progression	I:C0178874
for	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
and	O
5	B:C0049241
-	I:C0049241
hydroxymethylcytosine	I:C0049241
levels	O
and	O
also	O
DNA	O
promoter	O
methylation	O
profile	O
of	O
a	O
panel	O
of	O
genes	O
for	O
its	O
diagnostic	O
potential	O
.	O

In	O
this	O
study	O
,	O
we	O
tested	O
cervical	O
tissues	O
at	O
various	O
stages	O
of	O
tumor	O
progression	I:C0178874
for	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
and	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
levels	O
and	O
also	O
DNA	B:C0012854
promoter	O
methylation	O
profile	O
of	O
a	O
panel	O
of	O
genes	O
for	O
its	O
diagnostic	O
potential	O
.	O

In	O
this	O
study	O
,	O
we	O
tested	O
cervical	O
tissues	O
at	O
various	O
stages	O
of	O
tumor	O
progression	I:C0178874
for	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
and	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
levels	O
and	O
also	O
DNA	O
promoter	B:C0314621
methylation	O
profile	O
of	O
a	O
panel	O
of	O
genes	O
for	O
its	O
diagnostic	O
potential	O
.	O

In	O
this	O
study	O
,	O
we	O
tested	O
cervical	O
tissues	O
at	O
various	O
stages	O
of	O
tumor	O
progression	I:C0178874
for	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
and	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
levels	O
and	O
also	O
DNA	O
promoter	O
methylation	B:C0376452
profile	O
of	O
a	O
panel	O
of	O
genes	O
for	O
its	O
diagnostic	O
potential	O
.	O

In	O
this	O
study	O
,	O
we	O
tested	O
cervical	O
tissues	O
at	O
various	O
stages	O
of	O
tumor	O
progression	I:C0178874
for	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
and	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
levels	O
and	O
also	O
DNA	O
promoter	O
methylation	O
profile	B:C1979963
of	O
a	O
panel	O
of	O
genes	O
for	O
its	O
diagnostic	O
potential	O
.	O

In	O
this	O
study	O
,	O
we	O
tested	O
cervical	O
tissues	O
at	O
various	O
stages	O
of	O
tumor	O
progression	I:C0178874
for	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
and	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
levels	O
and	O
also	O
DNA	O
promoter	O
methylation	O
profile	O
of	O
a	O
panel	O
of	O
genes	B:C0017337
for	O
its	O
diagnostic	O
potential	O
.	O

In	O
total	O
,	O
5	B:C0049308
-	I:C0049308
methylcytosine	I:C0049308
,	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
,	O
and	O
promoter	O
methylation	O
of	O
33	O
genes	O
were	O
evaluated	O
by	O
reversed	O
-	I:C0008562
phase	I:C0008562
high	I:C0008562
-	I:C0008562
performance	I:C0008562
liquid	I:C0008562
chromatography	I:C0008562
,	O
enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
based	O
technique	O
,	O
and	O
bisulfate	O
-	I:C2936622
based	I:C2936622
next	I:C2936622
generation	I:C2936622
sequencing	I:C2936622
.	O

In	O
total	O
,	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
,	O
5	B:C0049241
-	I:C0049241
hydroxymethylcytosine	I:C0049241
,	O
and	O
promoter	O
methylation	O
of	O
33	O
genes	O
were	O
evaluated	O
by	O
reversed	O
-	I:C0008562
phase	I:C0008562
high	I:C0008562
-	I:C0008562
performance	I:C0008562
liquid	I:C0008562
chromatography	I:C0008562
,	O
enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
based	O
technique	O
,	O
and	O
bisulfate	O
-	I:C2936622
based	I:C2936622
next	I:C2936622
generation	I:C2936622
sequencing	I:C2936622
.	O

In	O
total	O
,	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
,	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
,	O
and	O
promoter	B:C0314621
methylation	O
of	O
33	O
genes	O
were	O
evaluated	O
by	O
reversed	O
-	I:C0008562
phase	I:C0008562
high	I:C0008562
-	I:C0008562
performance	I:C0008562
liquid	I:C0008562
chromatography	I:C0008562
,	O
enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
based	O
technique	O
,	O
and	O
bisulfate	O
-	I:C2936622
based	I:C2936622
next	I:C2936622
generation	I:C2936622
sequencing	I:C2936622
.	O

In	O
total	O
,	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
,	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
,	O
and	O
promoter	O
methylation	B:C0376452
of	O
33	O
genes	O
were	O
evaluated	O
by	O
reversed	O
-	I:C0008562
phase	I:C0008562
high	I:C0008562
-	I:C0008562
performance	I:C0008562
liquid	I:C0008562
chromatography	I:C0008562
,	O
enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
based	O
technique	O
,	O
and	O
bisulfate	O
-	I:C2936622
based	I:C2936622
next	I:C2936622
generation	I:C2936622
sequencing	I:C2936622
.	O

In	O
total	O
,	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
,	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
,	O
and	O
promoter	O
methylation	O
of	O
33	O
genes	B:C0017337
were	O
evaluated	O
by	O
reversed	O
-	I:C0008562
phase	I:C0008562
high	I:C0008562
-	I:C0008562
performance	I:C0008562
liquid	I:C0008562
chromatography	I:C0008562
,	O
enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
based	O
technique	O
,	O
and	O
bisulfate	O
-	I:C2936622
based	I:C2936622
next	I:C2936622
generation	I:C2936622
sequencing	I:C2936622
.	O

In	O
total	O
,	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
,	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
,	O
and	O
promoter	O
methylation	O
of	O
33	O
genes	O
were	O
evaluated	O
by	O
reversed	B:C0008562
-	I:C0008562
phase	I:C0008562
high	I:C0008562
-	I:C0008562
performance	I:C0008562
liquid	I:C0008562
chromatography	I:C0008562
,	O
enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
based	O
technique	O
,	O
and	O
bisulfate	O
-	I:C2936622
based	I:C2936622
next	I:C2936622
generation	I:C2936622
sequencing	I:C2936622
.	O

In	O
total	O
,	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
,	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
,	O
and	O
promoter	O
methylation	O
of	O
33	O
genes	O
were	O
evaluated	O
by	O
reversed	O
-	I:C0008562
phase	I:C0008562
high	I:C0008562
-	I:C0008562
performance	I:C0008562
liquid	I:C0008562
chromatography	I:C0008562
,	O
enzyme	B:C0014441
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
based	O
technique	O
,	O
and	O
bisulfate	O
-	I:C2936622
based	I:C2936622
next	I:C2936622
generation	I:C2936622
sequencing	I:C2936622
.	O

In	O
total	O
,	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
,	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
,	O
and	O
promoter	O
methylation	O
of	O
33	O
genes	O
were	O
evaluated	O
by	O
reversed	O
-	I:C0008562
phase	I:C0008562
high	I:C0008562
-	I:C0008562
performance	I:C0008562
liquid	I:C0008562
chromatography	I:C0008562
,	O
enzyme	O
-	I:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
based	O
technique	O
,	O
and	O
bisulfate	B:C2936622
-	I:C2936622
based	I:C2936622
next	I:C2936622
generation	I:C2936622
sequencing	I:C2936622
.	O

The	O
5	B:C0049308
-	I:C0049308
methylcytosine	I:C0049308
and	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
contents	O
were	O
significantly	O
reduced	O
in	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
and	O
receiver	O
operating	O
characteristic	O
curve	O
analysis	O
showed	O
a	O
significant	O
difference	O
in	O
(	O
1	O
)	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
between	O
normal	O
and	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
tissues	O
(	O
area	O
under	O
the	O
curve	O
=	O
0.946	O
)	O
and	O
(	O
2	O
)	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
levels	O
among	O
normal	O
,	O
squamous	O
intraepithelial	I:C0333873
lesions	I:C0333873
and	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
.	O

The	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
and	O
5	B:C0049241
-	I:C0049241
hydroxymethylcytosine	I:C0049241
contents	O
were	O
significantly	O
reduced	O
in	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
and	O
receiver	O
operating	O
characteristic	O
curve	O
analysis	O
showed	O
a	O
significant	O
difference	O
in	O
(	O
1	O
)	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
between	O
normal	O
and	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
tissues	O
(	O
area	O
under	O
the	O
curve	O
=	O
0.946	O
)	O
and	O
(	O
2	O
)	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
levels	O
among	O
normal	O
,	O
squamous	O
intraepithelial	I:C0333873
lesions	I:C0333873
and	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
.	O

The	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
and	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
contents	O
were	O
significantly	O
reduced	O
in	O
squamous	B:C0007137
cell	I:C0007137
carcinoma	I:C0007137
and	O
receiver	O
operating	O
characteristic	O
curve	O
analysis	O
showed	O
a	O
significant	O
difference	O
in	O
(	O
1	O
)	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
between	O
normal	O
and	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
tissues	O
(	O
area	O
under	O
the	O
curve	O
=	O
0.946	O
)	O
and	O
(	O
2	O
)	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
levels	O
among	O
normal	O
,	O
squamous	O
intraepithelial	I:C0333873
lesions	I:C0333873
and	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
.	O

The	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
and	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
contents	O
were	O
significantly	O
reduced	O
in	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
and	O
receiver	O
operating	O
characteristic	O
curve	O
analysis	B:C0936012
showed	O
a	O
significant	O
difference	O
in	O
(	O
1	O
)	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
between	O
normal	O
and	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
tissues	O
(	O
area	O
under	O
the	O
curve	O
=	O
0.946	O
)	O
and	O
(	O
2	O
)	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
levels	O
among	O
normal	O
,	O
squamous	O
intraepithelial	I:C0333873
lesions	I:C0333873
and	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
.	O

The	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
and	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
contents	O
were	O
significantly	O
reduced	O
in	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
and	O
receiver	O
operating	O
characteristic	O
curve	O
analysis	O
showed	O
a	O
significant	O
difference	O
in	O
(	O
1	O
)	O
5	B:C0049308
-	I:C0049308
methylcytosine	I:C0049308
between	O
normal	O
and	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
tissues	O
(	O
area	O
under	O
the	O
curve	O
=	O
0.946	O
)	O
and	O
(	O
2	O
)	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
levels	O
among	O
normal	O
,	O
squamous	O
intraepithelial	I:C0333873
lesions	I:C0333873
and	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
.	O

The	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
and	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
contents	O
were	O
significantly	O
reduced	O
in	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
and	O
receiver	O
operating	O
characteristic	O
curve	O
analysis	O
showed	O
a	O
significant	O
difference	O
in	O
(	O
1	O
)	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
between	O
normal	O
and	O
squamous	B:C0007137
cell	I:C0007137
carcinoma	I:C0007137
tissues	O
(	O
area	O
under	O
the	O
curve	O
=	O
0.946	O
)	O
and	O
(	O
2	O
)	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
levels	O
among	O
normal	O
,	O
squamous	O
intraepithelial	I:C0333873
lesions	I:C0333873
and	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
.	O

The	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
and	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
contents	O
were	O
significantly	O
reduced	O
in	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
and	O
receiver	O
operating	O
characteristic	O
curve	O
analysis	O
showed	O
a	O
significant	O
difference	O
in	O
(	O
1	O
)	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
between	O
normal	O
and	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
tissues	B:C0040300
(	O
area	O
under	O
the	O
curve	O
=	O
0.946	O
)	O
and	O
(	O
2	O
)	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
levels	O
among	O
normal	O
,	O
squamous	O
intraepithelial	I:C0333873
lesions	I:C0333873
and	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
.	O

The	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
and	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
contents	O
were	O
significantly	O
reduced	O
in	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
and	O
receiver	O
operating	O
characteristic	O
curve	O
analysis	O
showed	O
a	O
significant	O
difference	O
in	O
(	O
1	O
)	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
between	O
normal	O
and	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
tissues	O
(	O
area	O
under	O
the	O
curve	O
=	O
0.946	O
)	O
and	O
(	O
2	O
)	O
5	B:C0049241
-	I:C0049241
hydroxymethylcytosine	I:C0049241
levels	O
among	O
normal	O
,	O
squamous	O
intraepithelial	I:C0333873
lesions	I:C0333873
and	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
.	O

The	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
and	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
contents	O
were	O
significantly	O
reduced	O
in	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
and	O
receiver	O
operating	O
characteristic	O
curve	O
analysis	O
showed	O
a	O
significant	O
difference	O
in	O
(	O
1	O
)	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
between	O
normal	O
and	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
tissues	O
(	O
area	O
under	O
the	O
curve	O
=	O
0.946	O
)	O
and	O
(	O
2	O
)	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
levels	O
among	O
normal	B:C0221198
,	O
squamous	O
intraepithelial	I:C0333873
lesions	I:C0333873
and	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
.	O

The	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
and	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
contents	O
were	O
significantly	O
reduced	O
in	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
and	O
receiver	O
operating	O
characteristic	O
curve	O
analysis	O
showed	O
a	O
significant	O
difference	O
in	O
(	O
1	O
)	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
between	O
normal	O
and	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
tissues	O
(	O
area	O
under	O
the	O
curve	O
=	O
0.946	O
)	O
and	O
(	O
2	O
)	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
levels	O
among	O
normal	O
,	O
squamous	B:C0333873
intraepithelial	I:C0333873
lesions	I:C0333873
and	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
.	O

The	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
and	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
contents	O
were	O
significantly	O
reduced	O
in	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
and	O
receiver	O
operating	O
characteristic	O
curve	O
analysis	O
showed	O
a	O
significant	O
difference	O
in	O
(	O
1	O
)	O
5	O
-	I:C0049308
methylcytosine	I:C0049308
between	O
normal	O
and	O
squamous	O
cell	I:C0007137
carcinoma	I:C0007137
tissues	O
(	O
area	O
under	O
the	O
curve	O
=	O
0.946	O
)	O
and	O
(	O
2	O
)	O
5	O
-	I:C0049241
hydroxymethylcytosine	I:C0049241
levels	O
among	O
normal	O
,	O
squamous	O
intraepithelial	I:C0333873
lesions	I:C0333873
and	O
squamous	B:C0007137
cell	I:C0007137
carcinoma	I:C0007137
.	O

Analyses	B:C0936012
of	O
our	O
next	O
generation	I:C2936622
sequencing	I:C2936622
results	O
and	O
data	O
from	O
five	O
independent	O
published	O
studies	I:C1704324
consisting	O
of	O
191	O
normal	O
,	O
10	O
low	O
-	I:C1302773
grade	I:C1302773
squamous	I:C1302773
intraepithelial	I:C1302773
lesions	I:C1302773
,	O
21	O
high	O
-	I:C0333875
grade	I:C0333875
squamous	I:C0333875
intraepithelial	I:C0333875
lesions	I:C0333875
,	O
and	O
335	O
malignant	O
tissues	O
identified	O
a	O
panel	O
of	O
nine	O
genes	O
(	O
ARHGAP6	O
,	O
DAPK1	O
,	O
HAND2	O
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
NNAT	O
,	O
PCDH10	O
,	O
PROX1	O
,	O
PITX2	O
,	O
and	O
RAB6C	O
)	O
which	O
could	O
effectively	O
discriminate	O
among	O
the	O
various	O
groups	O
with	O
sensitivity	O
and	O
specificity	O
of	O
80%-100	O
%	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Analyses	O
of	O
our	O
next	B:C2936622
generation	I:C2936622
sequencing	I:C2936622
results	O
and	O
data	O
from	O
five	O
independent	O
published	O
studies	I:C1704324
consisting	O
of	O
191	O
normal	O
,	O
10	O
low	O
-	I:C1302773
grade	I:C1302773
squamous	I:C1302773
intraepithelial	I:C1302773
lesions	I:C1302773
,	O
21	O
high	O
-	I:C0333875
grade	I:C0333875
squamous	I:C0333875
intraepithelial	I:C0333875
lesions	I:C0333875
,	O
and	O
335	O
malignant	O
tissues	O
identified	O
a	O
panel	O
of	O
nine	O
genes	O
(	O
ARHGAP6	O
,	O
DAPK1	O
,	O
HAND2	O
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
NNAT	O
,	O
PCDH10	O
,	O
PROX1	O
,	O
PITX2	O
,	O
and	O
RAB6C	O
)	O
which	O
could	O
effectively	O
discriminate	O
among	O
the	O
various	O
groups	O
with	O
sensitivity	O
and	O
specificity	O
of	O
80%-100	O
%	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Analyses	O
of	O
our	O
next	O
generation	I:C2936622
sequencing	I:C2936622
results	O
and	O
data	O
from	O
five	O
independent	O
published	B:C1704324
studies	I:C1704324
consisting	O
of	O
191	O
normal	O
,	O
10	O
low	O
-	I:C1302773
grade	I:C1302773
squamous	I:C1302773
intraepithelial	I:C1302773
lesions	I:C1302773
,	O
21	O
high	O
-	I:C0333875
grade	I:C0333875
squamous	I:C0333875
intraepithelial	I:C0333875
lesions	I:C0333875
,	O
and	O
335	O
malignant	O
tissues	O
identified	O
a	O
panel	O
of	O
nine	O
genes	O
(	O
ARHGAP6	O
,	O
DAPK1	O
,	O
HAND2	O
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
NNAT	O
,	O
PCDH10	O
,	O
PROX1	O
,	O
PITX2	O
,	O
and	O
RAB6C	O
)	O
which	O
could	O
effectively	O
discriminate	O
among	O
the	O
various	O
groups	O
with	O
sensitivity	O
and	O
specificity	O
of	O
80%-100	O
%	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Analyses	O
of	O
our	O
next	O
generation	I:C2936622
sequencing	I:C2936622
results	O
and	O
data	O
from	O
five	O
independent	O
published	O
studies	I:C1704324
consisting	O
of	O
191	O
normal	B:C0221198
,	O
10	O
low	O
-	I:C1302773
grade	I:C1302773
squamous	I:C1302773
intraepithelial	I:C1302773
lesions	I:C1302773
,	O
21	O
high	O
-	I:C0333875
grade	I:C0333875
squamous	I:C0333875
intraepithelial	I:C0333875
lesions	I:C0333875
,	O
and	O
335	O
malignant	O
tissues	O
identified	O
a	O
panel	O
of	O
nine	O
genes	O
(	O
ARHGAP6	O
,	O
DAPK1	O
,	O
HAND2	O
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
NNAT	O
,	O
PCDH10	O
,	O
PROX1	O
,	O
PITX2	O
,	O
and	O
RAB6C	O
)	O
which	O
could	O
effectively	O
discriminate	O
among	O
the	O
various	O
groups	O
with	O
sensitivity	O
and	O
specificity	O
of	O
80%-100	O
%	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Analyses	O
of	O
our	O
next	O
generation	I:C2936622
sequencing	I:C2936622
results	O
and	O
data	O
from	O
five	O
independent	O
published	O
studies	I:C1704324
consisting	O
of	O
191	O
normal	O
,	O
10	O
low	B:C1302773
-	I:C1302773
grade	I:C1302773
squamous	I:C1302773
intraepithelial	I:C1302773
lesions	I:C1302773
,	O
21	O
high	O
-	I:C0333875
grade	I:C0333875
squamous	I:C0333875
intraepithelial	I:C0333875
lesions	I:C0333875
,	O
and	O
335	O
malignant	O
tissues	O
identified	O
a	O
panel	O
of	O
nine	O
genes	O
(	O
ARHGAP6	O
,	O
DAPK1	O
,	O
HAND2	O
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
NNAT	O
,	O
PCDH10	O
,	O
PROX1	O
,	O
PITX2	O
,	O
and	O
RAB6C	O
)	O
which	O
could	O
effectively	O
discriminate	O
among	O
the	O
various	O
groups	O
with	O
sensitivity	O
and	O
specificity	O
of	O
80%-100	O
%	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Analyses	O
of	O
our	O
next	O
generation	I:C2936622
sequencing	I:C2936622
results	O
and	O
data	O
from	O
five	O
independent	O
published	O
studies	I:C1704324
consisting	O
of	O
191	O
normal	O
,	O
10	O
low	O
-	I:C1302773
grade	I:C1302773
squamous	I:C1302773
intraepithelial	I:C1302773
lesions	I:C1302773
,	O
21	O
high	B:C0333875
-	I:C0333875
grade	I:C0333875
squamous	I:C0333875
intraepithelial	I:C0333875
lesions	I:C0333875
,	O
and	O
335	O
malignant	O
tissues	O
identified	O
a	O
panel	O
of	O
nine	O
genes	O
(	O
ARHGAP6	O
,	O
DAPK1	O
,	O
HAND2	O
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
NNAT	O
,	O
PCDH10	O
,	O
PROX1	O
,	O
PITX2	O
,	O
and	O
RAB6C	O
)	O
which	O
could	O
effectively	O
discriminate	O
among	O
the	O
various	O
groups	O
with	O
sensitivity	O
and	O
specificity	O
of	O
80%-100	O
%	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Analyses	O
of	O
our	O
next	O
generation	I:C2936622
sequencing	I:C2936622
results	O
and	O
data	O
from	O
five	O
independent	O
published	O
studies	I:C1704324
consisting	O
of	O
191	O
normal	O
,	O
10	O
low	O
-	I:C1302773
grade	I:C1302773
squamous	I:C1302773
intraepithelial	I:C1302773
lesions	I:C1302773
,	O
21	O
high	O
-	I:C0333875
grade	I:C0333875
squamous	I:C0333875
intraepithelial	I:C0333875
lesions	I:C0333875
,	O
and	O
335	O
malignant	B:C0006826
tissues	O
identified	O
a	O
panel	O
of	O
nine	O
genes	O
(	O
ARHGAP6	O
,	O
DAPK1	O
,	O
HAND2	O
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
NNAT	O
,	O
PCDH10	O
,	O
PROX1	O
,	O
PITX2	O
,	O
and	O
RAB6C	O
)	O
which	O
could	O
effectively	O
discriminate	O
among	O
the	O
various	O
groups	O
with	O
sensitivity	O
and	O
specificity	O
of	O
80%-100	O
%	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Analyses	O
of	O
our	O
next	O
generation	I:C2936622
sequencing	I:C2936622
results	O
and	O
data	O
from	O
five	O
independent	O
published	O
studies	I:C1704324
consisting	O
of	O
191	O
normal	O
,	O
10	O
low	O
-	I:C1302773
grade	I:C1302773
squamous	I:C1302773
intraepithelial	I:C1302773
lesions	I:C1302773
,	O
21	O
high	O
-	I:C0333875
grade	I:C0333875
squamous	I:C0333875
intraepithelial	I:C0333875
lesions	I:C0333875
,	O
and	O
335	O
malignant	O
tissues	B:C0040300
identified	O
a	O
panel	O
of	O
nine	O
genes	O
(	O
ARHGAP6	O
,	O
DAPK1	O
,	O
HAND2	O
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
NNAT	O
,	O
PCDH10	O
,	O
PROX1	O
,	O
PITX2	O
,	O
and	O
RAB6C	O
)	O
which	O
could	O
effectively	O
discriminate	O
among	O
the	O
various	O
groups	O
with	O
sensitivity	O
and	O
specificity	O
of	O
80%-100	O
%	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Analyses	O
of	O
our	O
next	O
generation	I:C2936622
sequencing	I:C2936622
results	O
and	O
data	O
from	O
five	O
independent	O
published	O
studies	I:C1704324
consisting	O
of	O
191	O
normal	O
,	O
10	O
low	O
-	I:C1302773
grade	I:C1302773
squamous	I:C1302773
intraepithelial	I:C1302773
lesions	I:C1302773
,	O
21	O
high	O
-	I:C0333875
grade	I:C0333875
squamous	I:C0333875
intraepithelial	I:C0333875
lesions	I:C0333875
,	O
and	O
335	O
malignant	O
tissues	O
identified	O
a	O
panel	O
of	O
nine	O
genes	B:C0017337
(	O
ARHGAP6	O
,	O
DAPK1	O
,	O
HAND2	O
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
NNAT	O
,	O
PCDH10	O
,	O
PROX1	O
,	O
PITX2	O
,	O
and	O
RAB6C	O
)	O
which	O
could	O
effectively	O
discriminate	O
among	O
the	O
various	O
groups	O
with	O
sensitivity	O
and	O
specificity	O
of	O
80%-100	O
%	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Analyses	O
of	O
our	O
next	O
generation	I:C2936622
sequencing	I:C2936622
results	O
and	O
data	O
from	O
five	O
independent	O
published	O
studies	I:C1704324
consisting	O
of	O
191	O
normal	O
,	O
10	O
low	O
-	I:C1302773
grade	I:C1302773
squamous	I:C1302773
intraepithelial	I:C1302773
lesions	I:C1302773
,	O
21	O
high	O
-	I:C0333875
grade	I:C0333875
squamous	I:C0333875
intraepithelial	I:C0333875
lesions	I:C0333875
,	O
and	O
335	O
malignant	O
tissues	O
identified	O
a	O
panel	O
of	O
nine	O
genes	O
(	O
ARHGAP6	B:C1412523
,	O
DAPK1	O
,	O
HAND2	O
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
NNAT	O
,	O
PCDH10	O
,	O
PROX1	O
,	O
PITX2	O
,	O
and	O
RAB6C	O
)	O
which	O
could	O
effectively	O
discriminate	O
among	O
the	O
various	O
groups	O
with	O
sensitivity	O
and	O
specificity	O
of	O
80%-100	O
%	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Analyses	O
of	O
our	O
next	O
generation	I:C2936622
sequencing	I:C2936622
results	O
and	O
data	O
from	O
five	O
independent	O
published	O
studies	I:C1704324
consisting	O
of	O
191	O
normal	O
,	O
10	O
low	O
-	I:C1302773
grade	I:C1302773
squamous	I:C1302773
intraepithelial	I:C1302773
lesions	I:C1302773
,	O
21	O
high	O
-	I:C0333875
grade	I:C0333875
squamous	I:C0333875
intraepithelial	I:C0333875
lesions	I:C0333875
,	O
and	O
335	O
malignant	O
tissues	O
identified	O
a	O
panel	O
of	O
nine	O
genes	O
(	O
ARHGAP6	O
,	O
DAPK1	B:C1413906
,	O
HAND2	O
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
NNAT	O
,	O
PCDH10	O
,	O
PROX1	O
,	O
PITX2	O
,	O
and	O
RAB6C	O
)	O
which	O
could	O
effectively	O
discriminate	O
among	O
the	O
various	O
groups	O
with	O
sensitivity	O
and	O
specificity	O
of	O
80%-100	O
%	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Analyses	O
of	O
our	O
next	O
generation	I:C2936622
sequencing	I:C2936622
results	O
and	O
data	O
from	O
five	O
independent	O
published	O
studies	I:C1704324
consisting	O
of	O
191	O
normal	O
,	O
10	O
low	O
-	I:C1302773
grade	I:C1302773
squamous	I:C1302773
intraepithelial	I:C1302773
lesions	I:C1302773
,	O
21	O
high	O
-	I:C0333875
grade	I:C0333875
squamous	I:C0333875
intraepithelial	I:C0333875
lesions	I:C0333875
,	O
and	O
335	O
malignant	O
tissues	O
identified	O
a	O
panel	O
of	O
nine	O
genes	O
(	O
ARHGAP6	O
,	O
DAPK1	O
,	O
HAND2	B:C1415467
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
NNAT	O
,	O
PCDH10	O
,	O
PROX1	O
,	O
PITX2	O
,	O
and	O
RAB6C	O
)	O
which	O
could	O
effectively	O
discriminate	O
among	O
the	O
various	O
groups	O
with	O
sensitivity	O
and	O
specificity	O
of	O
80%-100	O
%	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Analyses	O
of	O
our	O
next	O
generation	I:C2936622
sequencing	I:C2936622
results	O
and	O
data	O
from	O
five	O
independent	O
published	O
studies	I:C1704324
consisting	O
of	O
191	O
normal	O
,	O
10	O
low	O
-	I:C1302773
grade	I:C1302773
squamous	I:C1302773
intraepithelial	I:C1302773
lesions	I:C1302773
,	O
21	O
high	O
-	I:C0333875
grade	I:C0333875
squamous	I:C0333875
intraepithelial	I:C0333875
lesions	I:C0333875
,	O
and	O
335	O
malignant	O
tissues	O
identified	O
a	O
panel	O
of	O
nine	O
genes	O
(	O
ARHGAP6	O
,	O
DAPK1	O
,	O
HAND2	O
,	O
NKX2	B:C1417735
-	I:C1417735
2	I:C1417735
,	O
NNAT	O
,	O
PCDH10	O
,	O
PROX1	O
,	O
PITX2	O
,	O
and	O
RAB6C	O
)	O
which	O
could	O
effectively	O
discriminate	O
among	O
the	O
various	O
groups	O
with	O
sensitivity	O
and	O
specificity	O
of	O
80%-100	O
%	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Analyses	O
of	O
our	O
next	O
generation	I:C2936622
sequencing	I:C2936622
results	O
and	O
data	O
from	O
five	O
independent	O
published	O
studies	I:C1704324
consisting	O
of	O
191	O
normal	O
,	O
10	O
low	O
-	I:C1302773
grade	I:C1302773
squamous	I:C1302773
intraepithelial	I:C1302773
lesions	I:C1302773
,	O
21	O
high	O
-	I:C0333875
grade	I:C0333875
squamous	I:C0333875
intraepithelial	I:C0333875
lesions	I:C0333875
,	O
and	O
335	O
malignant	O
tissues	O
identified	O
a	O
panel	O
of	O
nine	O
genes	O
(	O
ARHGAP6	O
,	O
DAPK1	O
,	O
HAND2	O
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
NNAT	B:C1417747
,	O
PCDH10	O
,	O
PROX1	O
,	O
PITX2	O
,	O
and	O
RAB6C	O
)	O
which	O
could	O
effectively	O
discriminate	O
among	O
the	O
various	O
groups	O
with	O
sensitivity	O
and	O
specificity	O
of	O
80%-100	O
%	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Analyses	O
of	O
our	O
next	O
generation	I:C2936622
sequencing	I:C2936622
results	O
and	O
data	O
from	O
five	O
independent	O
published	O
studies	I:C1704324
consisting	O
of	O
191	O
normal	O
,	O
10	O
low	O
-	I:C1302773
grade	I:C1302773
squamous	I:C1302773
intraepithelial	I:C1302773
lesions	I:C1302773
,	O
21	O
high	O
-	I:C0333875
grade	I:C0333875
squamous	I:C0333875
intraepithelial	I:C0333875
lesions	I:C0333875
,	O
and	O
335	O
malignant	O
tissues	O
identified	O
a	O
panel	O
of	O
nine	O
genes	O
(	O
ARHGAP6	O
,	O
DAPK1	O
,	O
HAND2	O
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
NNAT	O
,	O
PCDH10	B:C1421975
,	O
PROX1	O
,	O
PITX2	O
,	O
and	O
RAB6C	O
)	O
which	O
could	O
effectively	O
discriminate	O
among	O
the	O
various	O
groups	O
with	O
sensitivity	O
and	O
specificity	O
of	O
80%-100	O
%	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Analyses	O
of	O
our	O
next	O
generation	I:C2936622
sequencing	I:C2936622
results	O
and	O
data	O
from	O
five	O
independent	O
published	O
studies	I:C1704324
consisting	O
of	O
191	O
normal	O
,	O
10	O
low	O
-	I:C1302773
grade	I:C1302773
squamous	I:C1302773
intraepithelial	I:C1302773
lesions	I:C1302773
,	O
21	O
high	O
-	I:C0333875
grade	I:C0333875
squamous	I:C0333875
intraepithelial	I:C0333875
lesions	I:C0333875
,	O
and	O
335	O
malignant	O
tissues	O
identified	O
a	O
panel	O
of	O
nine	O
genes	O
(	O
ARHGAP6	O
,	O
DAPK1	O
,	O
HAND2	O
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
NNAT	O
,	O
PCDH10	O
,	O
PROX1	B:C1418951
,	O
PITX2	O
,	O
and	O
RAB6C	O
)	O
which	O
could	O
effectively	O
discriminate	O
among	O
the	O
various	O
groups	O
with	O
sensitivity	O
and	O
specificity	O
of	O
80%-100	O
%	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Analyses	O
of	O
our	O
next	O
generation	I:C2936622
sequencing	I:C2936622
results	O
and	O
data	O
from	O
five	O
independent	O
published	O
studies	I:C1704324
consisting	O
of	O
191	O
normal	O
,	O
10	O
low	O
-	I:C1302773
grade	I:C1302773
squamous	I:C1302773
intraepithelial	I:C1302773
lesions	I:C1302773
,	O
21	O
high	O
-	I:C0333875
grade	I:C0333875
squamous	I:C0333875
intraepithelial	I:C0333875
lesions	I:C0333875
,	O
and	O
335	O
malignant	O
tissues	O
identified	O
a	O
panel	O
of	O
nine	O
genes	O
(	O
ARHGAP6	O
,	O
DAPK1	O
,	O
HAND2	O
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
NNAT	O
,	O
PCDH10	O
,	O
PROX1	O
,	O
PITX2	B:C1418596
,	O
and	O
RAB6C	O
)	O
which	O
could	O
effectively	O
discriminate	O
among	O
the	O
various	O
groups	O
with	O
sensitivity	O
and	O
specificity	O
of	O
80%-100	O
%	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Analyses	O
of	O
our	O
next	O
generation	I:C2936622
sequencing	I:C2936622
results	O
and	O
data	O
from	O
five	O
independent	O
published	O
studies	I:C1704324
consisting	O
of	O
191	O
normal	O
,	O
10	O
low	O
-	I:C1302773
grade	I:C1302773
squamous	I:C1302773
intraepithelial	I:C1302773
lesions	I:C1302773
,	O
21	O
high	O
-	I:C0333875
grade	I:C0333875
squamous	I:C0333875
intraepithelial	I:C0333875
lesions	I:C0333875
,	O
and	O
335	O
malignant	O
tissues	O
identified	O
a	O
panel	O
of	O
nine	O
genes	O
(	O
ARHGAP6	O
,	O
DAPK1	O
,	O
HAND2	O
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
NNAT	O
,	O
PCDH10	O
,	O
PROX1	O
,	O
PITX2	O
,	O
and	O
RAB6C	B:C1424353
)	O
which	O
could	O
effectively	O
discriminate	O
among	O
the	O
various	O
groups	O
with	O
sensitivity	O
and	O
specificity	O
of	O
80%-100	O
%	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Furthermore	O
,	O
12	O
gene	B:C0314621
promoters	I:C0314621
(	O
ARHGAP6	O
,	O
HAND2	O
,	O
LHX9	O
,	O
HEY2	O
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
PCDH10	O
,	O
PITX2	O
,	O
PROX1	O
,	O
TBX3	O
,	O
IKBKG	O
,	O
RAB6C	O
,	O
and	O
DAPK1	O
)	O
were	O
also	O
methylated	O
in	O
one	O
or	O
more	O
of	O
the	O
cervical	O
cancer	I:C4048328
cell	O
lines	I:C0007600
tested	O
.	O

Furthermore	O
,	O
12	O
gene	O
promoters	I:C0314621
(	O
ARHGAP6	B:C1412523
,	O
HAND2	O
,	O
LHX9	O
,	O
HEY2	O
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
PCDH10	O
,	O
PITX2	O
,	O
PROX1	O
,	O
TBX3	O
,	O
IKBKG	O
,	O
RAB6C	O
,	O
and	O
DAPK1	O
)	O
were	O
also	O
methylated	O
in	O
one	O
or	O
more	O
of	O
the	O
cervical	O
cancer	I:C4048328
cell	O
lines	I:C0007600
tested	O
.	O

Furthermore	O
,	O
12	O
gene	O
promoters	I:C0314621
(	O
ARHGAP6	O
,	O
HAND2	B:C1415467
,	O
LHX9	O
,	O
HEY2	O
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
PCDH10	O
,	O
PITX2	O
,	O
PROX1	O
,	O
TBX3	O
,	O
IKBKG	O
,	O
RAB6C	O
,	O
and	O
DAPK1	O
)	O
were	O
also	O
methylated	O
in	O
one	O
or	O
more	O
of	O
the	O
cervical	O
cancer	I:C4048328
cell	O
lines	I:C0007600
tested	O
.	O

Furthermore	O
,	O
12	O
gene	O
promoters	I:C0314621
(	O
ARHGAP6	O
,	O
HAND2	O
,	O
LHX9	B:C1422495
,	O
HEY2	O
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
PCDH10	O
,	O
PITX2	O
,	O
PROX1	O
,	O
TBX3	O
,	O
IKBKG	O
,	O
RAB6C	O
,	O
and	O
DAPK1	O
)	O
were	O
also	O
methylated	O
in	O
one	O
or	O
more	O
of	O
the	O
cervical	O
cancer	I:C4048328
cell	O
lines	I:C0007600
tested	O
.	O

Furthermore	O
,	O
12	O
gene	O
promoters	I:C0314621
(	O
ARHGAP6	O
,	O
HAND2	O
,	O
LHX9	O
,	O
HEY2	B:C1415525
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
PCDH10	O
,	O
PITX2	O
,	O
PROX1	O
,	O
TBX3	O
,	O
IKBKG	O
,	O
RAB6C	O
,	O
and	O
DAPK1	O
)	O
were	O
also	O
methylated	O
in	O
one	O
or	O
more	O
of	O
the	O
cervical	O
cancer	I:C4048328
cell	O
lines	I:C0007600
tested	O
.	O

Furthermore	O
,	O
12	O
gene	O
promoters	I:C0314621
(	O
ARHGAP6	O
,	O
HAND2	O
,	O
LHX9	O
,	O
HEY2	O
,	O
NKX2	B:C1417735
-	I:C1417735
2	I:C1417735
,	O
PCDH10	O
,	O
PITX2	O
,	O
PROX1	O
,	O
TBX3	O
,	O
IKBKG	O
,	O
RAB6C	O
,	O
and	O
DAPK1	O
)	O
were	O
also	O
methylated	O
in	O
one	O
or	O
more	O
of	O
the	O
cervical	O
cancer	I:C4048328
cell	O
lines	I:C0007600
tested	O
.	O

Furthermore	O
,	O
12	O
gene	O
promoters	I:C0314621
(	O
ARHGAP6	O
,	O
HAND2	O
,	O
LHX9	O
,	O
HEY2	O
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
PCDH10	B:C1421975
,	O
PITX2	O
,	O
PROX1	O
,	O
TBX3	O
,	O
IKBKG	O
,	O
RAB6C	O
,	O
and	O
DAPK1	O
)	O
were	O
also	O
methylated	O
in	O
one	O
or	O
more	O
of	O
the	O
cervical	O
cancer	I:C4048328
cell	O
lines	I:C0007600
tested	O
.	O

Furthermore	O
,	O
12	O
gene	O
promoters	I:C0314621
(	O
ARHGAP6	O
,	O
HAND2	O
,	O
LHX9	O
,	O
HEY2	O
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
PCDH10	O
,	O
PITX2	B:C1418596
,	O
PROX1	O
,	O
TBX3	O
,	O
IKBKG	O
,	O
RAB6C	O
,	O
and	O
DAPK1	O
)	O
were	O
also	O
methylated	O
in	O
one	O
or	O
more	O
of	O
the	O
cervical	O
cancer	I:C4048328
cell	O
lines	I:C0007600
tested	O
.	O

Furthermore	O
,	O
12	O
gene	O
promoters	I:C0314621
(	O
ARHGAP6	O
,	O
HAND2	O
,	O
LHX9	O
,	O
HEY2	O
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
PCDH10	O
,	O
PITX2	O
,	O
PROX1	B:C1418951
,	O
TBX3	O
,	O
IKBKG	O
,	O
RAB6C	O
,	O
and	O
DAPK1	O
)	O
were	O
also	O
methylated	O
in	O
one	O
or	O
more	O
of	O
the	O
cervical	O
cancer	I:C4048328
cell	O
lines	I:C0007600
tested	O
.	O

Furthermore	O
,	O
12	O
gene	O
promoters	I:C0314621
(	O
ARHGAP6	O
,	O
HAND2	O
,	O
LHX9	O
,	O
HEY2	O
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
PCDH10	O
,	O
PITX2	O
,	O
PROX1	O
,	O
TBX3	B:C1420613
,	O
IKBKG	O
,	O
RAB6C	O
,	O
and	O
DAPK1	O
)	O
were	O
also	O
methylated	O
in	O
one	O
or	O
more	O
of	O
the	O
cervical	O
cancer	I:C4048328
cell	O
lines	I:C0007600
tested	O
.	O

Furthermore	O
,	O
12	O
gene	O
promoters	I:C0314621
(	O
ARHGAP6	O
,	O
HAND2	O
,	O
LHX9	O
,	O
HEY2	O
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
PCDH10	O
,	O
PITX2	O
,	O
PROX1	O
,	O
TBX3	O
,	O
IKBKG	B:C1416380
,	O
RAB6C	O
,	O
and	O
DAPK1	O
)	O
were	O
also	O
methylated	O
in	O
one	O
or	O
more	O
of	O
the	O
cervical	O
cancer	I:C4048328
cell	O
lines	I:C0007600
tested	O
.	O

Furthermore	O
,	O
12	O
gene	O
promoters	I:C0314621
(	O
ARHGAP6	O
,	O
HAND2	O
,	O
LHX9	O
,	O
HEY2	O
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
PCDH10	O
,	O
PITX2	O
,	O
PROX1	O
,	O
TBX3	O
,	O
IKBKG	O
,	O
RAB6C	B:C1424353
,	O
and	O
DAPK1	O
)	O
were	O
also	O
methylated	O
in	O
one	O
or	O
more	O
of	O
the	O
cervical	O
cancer	I:C4048328
cell	O
lines	I:C0007600
tested	O
.	O

Furthermore	O
,	O
12	O
gene	O
promoters	I:C0314621
(	O
ARHGAP6	O
,	O
HAND2	O
,	O
LHX9	O
,	O
HEY2	O
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
PCDH10	O
,	O
PITX2	O
,	O
PROX1	O
,	O
TBX3	O
,	O
IKBKG	O
,	O
RAB6C	O
,	O
and	O
DAPK1	B:C1413906
)	O
were	O
also	O
methylated	O
in	O
one	O
or	O
more	O
of	O
the	O
cervical	O
cancer	I:C4048328
cell	O
lines	I:C0007600
tested	O
.	O

Furthermore	O
,	O
12	O
gene	O
promoters	I:C0314621
(	O
ARHGAP6	O
,	O
HAND2	O
,	O
LHX9	O
,	O
HEY2	O
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
PCDH10	O
,	O
PITX2	O
,	O
PROX1	O
,	O
TBX3	O
,	O
IKBKG	O
,	O
RAB6C	O
,	O
and	O
DAPK1	O
)	O
were	O
also	O
methylated	B:C0376452
in	O
one	O
or	O
more	O
of	O
the	O
cervical	O
cancer	I:C4048328
cell	O
lines	I:C0007600
tested	O
.	O

Furthermore	O
,	O
12	O
gene	O
promoters	I:C0314621
(	O
ARHGAP6	O
,	O
HAND2	O
,	O
LHX9	O
,	O
HEY2	O
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
PCDH10	O
,	O
PITX2	O
,	O
PROX1	O
,	O
TBX3	O
,	O
IKBKG	O
,	O
RAB6C	O
,	O
and	O
DAPK1	O
)	O
were	O
also	O
methylated	O
in	O
one	O
or	O
more	O
of	O
the	O
cervical	B:C4048328
cancer	I:C4048328
cell	O
lines	I:C0007600
tested	O
.	O

Furthermore	O
,	O
12	O
gene	O
promoters	I:C0314621
(	O
ARHGAP6	O
,	O
HAND2	O
,	O
LHX9	O
,	O
HEY2	O
,	O
NKX2	O
-	I:C1417735
2	I:C1417735
,	O
PCDH10	O
,	O
PITX2	O
,	O
PROX1	O
,	O
TBX3	O
,	O
IKBKG	O
,	O
RAB6C	O
,	O
and	O
DAPK1	O
)	O
were	O
also	O
methylated	O
in	O
one	O
or	O
more	O
of	O
the	O
cervical	O
cancer	I:C4048328
cell	B:C0007600
lines	I:C0007600
tested	O
.	O

The	O
global	O
and	O
gene	B:C0017337
-	O
specific	O
methylation	O
of	O
the	O
panel	O
of	O
genes	O
identified	O
in	O
our	O
study	O
may	O
serve	O
as	O
useful	O
biomarkers	O
for	O
the	O
early	O
detection	O
and	O
clinical	O
management	I:C1516615
of	O
cervical	O
cancer	I:C4048328
.	O

The	O
global	O
and	O
gene	O
-	O
specific	O
methylation	B:C0376452
of	O
the	O
panel	O
of	O
genes	O
identified	O
in	O
our	O
study	O
may	O
serve	O
as	O
useful	O
biomarkers	O
for	O
the	O
early	O
detection	O
and	O
clinical	O
management	I:C1516615
of	O
cervical	O
cancer	I:C4048328
.	O

The	O
global	O
and	O
gene	O
-	O
specific	O
methylation	O
of	O
the	O
panel	O
of	O
genes	B:C0017337
identified	O
in	O
our	O
study	O
may	O
serve	O
as	O
useful	O
biomarkers	O
for	O
the	O
early	O
detection	O
and	O
clinical	O
management	I:C1516615
of	O
cervical	O
cancer	I:C4048328
.	O

The	O
global	O
and	O
gene	O
-	O
specific	O
methylation	O
of	O
the	O
panel	O
of	O
genes	O
identified	O
in	O
our	O
study	B:C2603343
may	O
serve	O
as	O
useful	O
biomarkers	O
for	O
the	O
early	O
detection	O
and	O
clinical	O
management	I:C1516615
of	O
cervical	O
cancer	I:C4048328
.	O

The	O
global	O
and	O
gene	O
-	O
specific	O
methylation	O
of	O
the	O
panel	O
of	O
genes	O
identified	O
in	O
our	O
study	O
may	O
serve	O
as	O
useful	O
biomarkers	B:C0041366
for	O
the	O
early	O
detection	O
and	O
clinical	O
management	I:C1516615
of	O
cervical	O
cancer	I:C4048328
.	O

The	O
global	O
and	O
gene	O
-	O
specific	O
methylation	O
of	O
the	O
panel	O
of	O
genes	O
identified	O
in	O
our	O
study	O
may	O
serve	O
as	O
useful	O
biomarkers	O
for	O
the	O
early	O
detection	B:C1511790
and	O
clinical	O
management	I:C1516615
of	O
cervical	O
cancer	I:C4048328
.	O

The	O
global	O
and	O
gene	O
-	O
specific	O
methylation	O
of	O
the	O
panel	O
of	O
genes	O
identified	O
in	O
our	O
study	O
may	O
serve	O
as	O
useful	O
biomarkers	O
for	O
the	O
early	O
detection	O
and	O
clinical	B:C1516615
management	I:C1516615
of	O
cervical	O
cancer	I:C4048328
.	O

The	O
global	O
and	O
gene	O
-	O
specific	O
methylation	O
of	O
the	O
panel	O
of	O
genes	O
identified	O
in	O
our	O
study	O
may	O
serve	O
as	O
useful	O
biomarkers	O
for	O
the	O
early	O
detection	O
and	O
clinical	O
management	I:C1516615
of	O
cervical	B:C4048328
cancer	I:C4048328
.	O

